CHM chimeric therapeutics limited

A lot of that package is directly correlated to previous...

  1. 4,721 Posts.
    lightbulb Created with Sketch. 2169
    A lot of that package is directly correlated to previous employment, and employee performance type shares that needed to be left behind because of jumping ship. This share compensation thing is normal practice in USA biotechnology companies when employees move. CHM attracted some respected big hitters because of this.

    The performance share bit of the package has now concluded. So total package amount has now reduced.

    But by attracting these professionals, CHM has reduced time in clinic of their drugs. This is because all that experience from progressing the previous approved CarT drugs from an idea to an approved drug has come across with them. Every month saved in development equals an enormous amount of money (CarT aint cheap). Trial cohort sizes and endpoints will be exactly the right ones that are needed for example. The contacts they have with FDA and industry have value.

    Sometimes having the right people in the right jobs is an overlooked value adder. It is here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $12.99M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $949 312.2K

Buyers (Bids)

No. Vol. Price($)
70 67782438 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 91927011 27
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.